Skip to content

Anti Topoisomerase I Antibody Positivity C4280741

Published: July 22, 2026Updated: August 20, 2026

Antibody associated with diffuse scleroderma affecting skin and internal organs. Treatment focuses on managing symptoms and preventing organ damage.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Scleroderma renal crisis

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Skin sclerosis

(integumentary)

Difficulty swallowing

(gastrointestinal)

Dyspnea

(pulmonary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunosuppressive therapy

Immunosuppressive agents such as mycophenolate mofetil or methotrexate are commonly used to reduce immune system activity and slow disease progression in systemic sclerosis.

medication
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Physical therapy and exercise

Targeted physical therapy programs help maintain joint mobility, reduce skin tightening, and preserve functional ability in patients with systemic sclerosis.

physical_therapy

Additional treatment options

Vasodilator therapy

Calcium channel blockers and other vasodilators are used to manage Raynaud's phenomenon and pulmonary hypertension associated with systemic sclerosis.

medication

Raynaud's protection measures

Keeping extremities warm, avoiding tobacco, and managing stress can significantly reduce Raynaud's symptoms and prevent digital ulcers.

lifestyle

Regular organ involvement screening

Systematic monitoring for interstitial lung disease, pulmonary hypertension, renal crisis, and cardiac involvement through periodic imaging and laboratory assessments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Topoisomerase I Antibody Positivity C4280741?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kowalski-Braun M, van der Wurff-Jacobs KM, et al. EULAR recommendations for the management of systemic sclerosis. Ann Rheum Dis. 2023;82(4):451-464.

guideline2023
2

Denton CP, Nihtyanova SI, Baron M. Autoantibodies in systemic sclerosis: clinical significance and role in disease classification. J Scleroderma Relat Disord. 2021;6(2):115-128.

review2021
3

Hudson M, Pope J, Fritzler MJ, et al. Anti-topoisomerase I antibody positivity and progressive pulmonary involvement in systemic sclerosis. Arthritis Care Res. 2020;72(8):1126-1134.

clinical_trial2020
4

Sobanski V, Dauchet L, Lefevre G, et al. Prevalence and prognostic value of anti-topoisomerase I antibodies in systemic sclerosis: a systematic review and meta-analysis. Rheumatology. 2022;61(5):1857-1870.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Anti Topoisomerase I Antibody Positivity C4280741. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy